安进的争议事件
以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。
2026
法国在出现死亡关联后召回Tavneos批次
宣布召回
法国药品安全机构ANSM表示，法国境内所有Tavneos批次将于8月19日开始召回。该药由美国生物技术公司安进生产，并由全球不同合作伙伴药企销售，此前在日本被指与20例死亡相关。欧盟委员会本月早些时候已撤销该药的上市许可。
品牌回应
召回 — France's medicine safety agency ANSM
"The recall of all batches available in France will begin on August 19," France's medicine safety agency ANSM said in a statement.
来源摘录
A drug called Tavneos used to treat rare autoimmune diseases will be pulled from the shelves in France, the country's medicine watchdog said Wednesday, after it was linked to 20 deaths in Japan.
"The recall of all batches available in France will begin on August 19," France's medicine safety agency ANSM said in a statement.
Tavneos is made by the U.S. biotech firm Amgen and is sold by different partner pharmaceutical companies around the world.
2012